Brachytherapy

In the 1960’s, the permanent insertion of radioactive material into the prostate gland developed. Doctors tried the interstitial insertion of gold -198 or Iodine - 125 seeds into the prostate gland in conjunction with EBRT. Unfortunately, the success of these techniques was poor due to the inability to see the prostate gland and the surrounding organs. Not until around 1980’s, when doctors began to use a transperineal needle temple, transperineal needles, and the transrectal ultrasound, did Brachytherapy become a viable prostate cancer treatment.

Types Of Prostate Brachytherapy

There are two types of Brachytherapy that are used in the treatment of prostate cancer: Permanent Low Dose Radiation (LDR) and Temporary High Dose Radiation (HDR).

LDR Brachytherapy uses iodine -125 and palladium -103 stored in titanium cases, usually referred to as Brachytherapy Seeds. As the name Permanent Brachytherapy suggest, the seeds are permanently left inside the prostate gland. Over the course of their radioactive lives, the seeds will continuously emit low levels of radiation.

HDR Brachytherapy uses a single radioactive seed made of iridium -194, which is sometimes referred to as an iridium wire. Soft flexible plastic catheters are inserted through the perineum, and into the prostate gland. HDR Brachytherapy entails an overnight stay in the hospital, during which a patient undergoes two or three treatments with the wire through each catheter.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

VPC Terry Fox team 2016

Terry Fox Run - September 20, 2020

The 40th annual Terry Fox Run takes place on Sunday September 20 across Canada, as a virtual event.  Please consider donating to or joining our TFRI-VPC team as we raise funds to enable The Terry Fox Foundation & The Terry Fox Research Institute to continue their support of innovative and progressive cancer research programs

Employment

Work at the Vancouver Prostate Centre

Friday, January 22, 2021

Dr. Nappi receives MSFHR 2020 Health Professional-Investigator Award

Dr. Nappi
Wednesday, December 16, 2020

Dr. Nappi awarded a 2020 PCF Young Investigator Award